Cystic Fibrosis

March 2, 2016March 2, 2016

AffloVest, for Lung and Respiratory Conditions, to Be Made in the USA

International Biophysics Corp. recently announced that the company will now manufacture its AffloVest in the United States. AffloVest is the first portable High Frequency Chest Wall Oscillation (HFCWO) medical device which can provide critical ... Read more

March 1, 2016March 1, 2016

Diagnosing Lung Conditions Takes Step Forward With New Electronic Stethoscope, Computer Program

COPD, Cystic Fibrosis, News

The physician’s stethoscope, an iconic instrument of the medical profession, is being transitioned into the digital era. Scientists at Japan’s Hiroshima and Fukushima Medical Universities have developed a computer program ... Read more

February 26, 2016February 26, 2016

XOR-Labs Receives $2.6M to Advance Work in Improving the Quality of Donor Lungs

COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Cancer, News

XENiOS, a German company specializing in medical devices for minimally invasive lung-and-heart assist, recently announced that it has invested $2.6 million in XOR-Labs Toronto, a spin-off with the potential to markedly improve the ... Read more

February 23, 2016February 23, 2016

New Approach to Cystic Fibrosis Targets Anomaly Protein and Naturally Occurring Substance

Cystic Fibrosis, News

A study from researchers at Eindhoven University of Technology in the Netherlands and McGill University in Montreal, Canada, has demonstrated important progress toward the development of a new drug to battle cystic fibrosis ... Read more

February 23, 2016May 13, 2016

Capsugel and Pulmatrix Partnering to Develop Inhaled Therapeutics for Range of Lung Diseases

COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News

Capsugel and Pulmatrix, Inc., entered a partnership to advance the development and manufacture of inhaled therapeutics to treat serious pulmonary diseases, based on Pulmatrix’s iSPERSE technology. “This collaboration provides us with ... Read more

February 10, 2016February 18, 2016

Vertex CF Drug, Kalydeco, Rejected as Therapy for Specific Group of Mutations by FDA

Cystic Fibrosis, News

Vertex Pharmaceuticals recently received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) stating that its supplemental New Drug Application (sNDA) could not be approved in its current ... Read more

February 5, 2016February 18, 2016

New, One-Step Cystic Fibrosis Test for Newborns May Be More Reliable Than Standard

Cystic Fibrosis, News

A recent study, performed at Stanford University School of Medicine in collaboration with the University of Texas MD Anderson Cancer Center and the California Department of Public Health, reported a new, ... Read more

February 3, 2016February 18, 2016

3 Researchers Win Awards to Improve Diagnostic Tests for Cystic Fibrosis, Other Diseases

Cystic Fibrosis, News

Three researchers at Case Western Reserve University were recently awarded funding to develop new technologies for cystic fibrosis, malaria, and sickle cell anemia. The funds were granted by the National Center ... Read more

February 2, 2016February 3, 2016

FDA Approves IND Application for Multidrug-Resistant Bacterial Infections

Bronchiectasis, COPD, Cystic Fibrosis, Emphysema, News, Pneumonia

Matinas BioPharma Holdings recently announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application, and the company can now begin a Phase 1 clinical trial to ... Read more

February 1, 2016February 3, 2016

Promising Drug Candidate Tackles Wide Variety of Antibiotic-Resistant Infections

Cystic Fibrosis, News, Pneumonia

New York City-based pharma company TGV-Laboratories recently presented a promising compound, Mul-1867, for the treatment of several antibiotic-resistant fungal and bacterial infections – a growing problem that has been estimated to take ... Read more